Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib.
Shuya Takashima, Noboru Yamamoto, Taro Semba, Kohei Yamaguchi, Yohei Otake, Keisuke Yasuda, Daiko Matsuoka, Satoshi Shiono, Kohei Shitara, Kan Yonemori, Shunsuke Kondo, Kazuki Sudo, Satoru Iwasa, Yuki Katsuya, Shu Yazaki, Yoshiaki Nakamura, Makoto Nishino, Hanae Ida, Toshio Shimizu, Jun Sato, Takafumi Koyama, Takao Takase, Takuya Suzuki
Cancer research communications 2023;3(7):1189-1199